1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCHERISH Pilot Grant Program is sponsored by CHERISH Research. Provides funding for early-career researchers to conduct health economic research on substance use and HCV/HIV care.
Get alerted about grants like this
Get emailed when new opportunities from “CHERISH Research” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
We equip early-career researchers with the tools to explore research opportunities, expand networks, and lay the groundwork for future economic research. We are making investments to grow the next generation of substance use researchers.
Through CHERISH pilot grants, we support early-career researchers and trainees to become proficient with health economic methods and lead innovative economic studies of substance use disorder and HCV and HIV treatment interventions. CHERISH works with early-career researchers to ensure that pilot studies on substance use research are responsive to the rapidly changing healthcare landscape.
Our pilot grant program is geared towards supporting recipients through each phase of their research project. Funded researchers receive curated training on economic research and dissemination, peer-to-peer mentorship, and opportunities to connect with CHERISH Research Affiliates and investigators across the United States.
Recipients can expand their research scope by investigating innovative methodologies or applications and collecting preliminary data to inform future grant proposals. Past grantees have acknowledged the support of the CHERISH pilot grant program in their scientific publications, national conference presentations, and grant submissions. Applications for Cycle 12 (2026-2027): Now Closed Applications for 2026-2027 are now closed.
CHERISH funds health economic research projects on healthcare utilization, health outcomes, and health-related behaviors consistent with our mission. With each application cycle, starting in the fall, we highlight topics of interest that reflect our mission and meet the evolving needs and priorities of substance use disorder research.
Applicants can be located at any US-based institution; however, they must fulfill at least one of the following criteria: Postdoctoral fellow or trainee under the mentorship of a CHERISH investigator , CHERISH Research Affiliate , or CHERISH advisory board member An investigator nominated by a CHERISH investigator, CHERISH Research Affiliate, or CHERISH advisory board member A CHERISH investigator, CHERISH Research Affiliate, or CHERISH advisory board member Priority consideration will be given to: New or Early Stage Investigators as defined by NIH Investigators new to the field of health economics or substance use disorders Individuals who have lived/living experience or perspectives reflective of populations impacted by substance use disorders Letter of Intent Submission: January 9, 2026 Proposal Submission: February 20, 2026 Proposal Review: April 2026 Frequently Asked Questions Eligibility is based on being a trainee of a CHERISH investigator/affiliate or being nominated by one.
How does the nomination process usually look like? You do not need to have a sponsor in place to apply or submit a letter of intent (LOI). After reviewing your LOI, we can connect you to a potential sponsor within CHERISH.
If you are not already connected to a CHERISH Research Affiliate or someone from our network, please reach out to us. What should I ask from a sponsor (e.g., letter of support or co-authorship)? At the minimum, a sponsor can review your proposal and acknowledge in a letter of support that your project is consistent with NIH’s priorities for health economics and a good fit for the CHERISH pilot grant.
They do not need specify a time, FTE, or co-authorship commitment. Are there examples of project proposals that are not likely to be funded? Project proposals are not likely to be funded if the relationship to health outcomes is unclear or distantly removed, or if the proposal does not consider health-related behaviors, healthcare utilization, or health outcomes.
How do you recommend integrating protected time with our department? Pilot grantees use the funds for a variety of purposes, such as to support investigator or research staff salary or to purchase access to a large database.
If you are devoting time that is supported by your institution, you should reflect this as donated time in your budget and budget justification, We understand that your needs may change, and after you’re awarded the pilot grant you may reallocate funds after seeking our permission.
--> Pilot Grants in Action Announcing the 2026-2027 CHERISH Pilot Grant Awardees Four early-career researchers from Weill Cornell Medicine, Boston Medical Center, University of Pennsylvania, and Virginia Commonwealth University, have been awarded the 12th cycle of the CHERISH pilot grant. Pilot grants are an important funding source for early-career researchers seeking to become independent scientists.
The one-year CHERISH pilot grant, funded up to $20,000 per project, allows […] 07/06/26 Research Highlight Continuous Medicaid Coverage for Pregnant Patients and Its Impact on OUD Treatment Medications for opioid use disorder (MOUD) are the gold standard of care to treat opioid use disorder among pregnant patients.
Medicaid, which covers nearly 8 in 10 pregnant women with OUD in the U.S., is a critical resource for this population to access and afford MOUD before and after childbirth.
Two major legislations passed in […] 03/10/26 Research Highlight Prior Authorization Bans for Buprenorphine Alone May Not Improve Treatment Retention State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report.
Though prescription buprenorphine can be a life-saving treatment that relieves opioid cravings and withdrawal symptoms, adherence to the medication is low. […] Catching Up with Pilot Grant Recipients Bre Biondi and Fiona Gispen The CHERISH pilot grant application for the 2026-2027 funding period is open.
In preparation for this 12th cycle, we invited Breanne (Bre) Biondi and Fiona Gispen, CHERISH pilot grantees from the 2024-2025 cohort, to reflect on their overall experience and share tips on preparing the pilot grant application.
CHERISH Pilot Grant Director Brandon Aden, Senior […] 11/13/25 Research Highlight Pilot Grant Analysis Examines Prior Authorization Trends for MOUD in Private Insurance There is a growing body of research illustrating a movement to remove prior authorization for medications for opioid use disorder (MOUD). Prior authorization requires providers to request approval from an insurer before providing a medication or service.
This process is historically enforced for a wide range of medications, including certain MOUD, and has been found […] 11/10/25 Research Highlight CHERISH Pilot Grantee Highlight Low PrEP Use Among Women The introduction of pre-exposure prophylaxis (PrEP) for HIV prevention has been paramount to reducing HIV transmission and improving the lives of people living with HIV.
However, trends in HIV cases and PrEP uptake suggest unaddressed opportunities to reach women and other communities at risk of contracting HIV.
Cis-gender women represent 20% of new HIV cases […] Announcing the 2025-2026 CHERISH Pilot Grant Recipients The CHERISH Pilot Grant & Training Core is pleased to support five early-career researchers in their academic journey leading pilot investigations on healthcare utilization, health outcomes, and health-related behaviors related to the care of people who use substances.
The funded projects respond to CHERISH’s overall mission and topics of special interest in the call for […] Catching Up with Pilot Grant Recipients Sierra Castedo de Martell and Bulat Idrisov In preparation for the 11th cycle of CHERISH pilot grants that is now open, former pilot grant recipients Sierra Castedo de Martell and Bulat Idrisov joined CHERISH Pilot Grant Director Brandon Aden, Senior Research Program Manager Jared Leff, and Communications Manager Bonnie Tse online to meet prospective applicants.
Attendees raised questions about eligibility, the pilot […] 11/06/24 Research Highlight Racial and Ethnic Disparities Along the Hepatitis C Care Cascade Among Priority Populations Over the last two decades, injection opioid use has increased among reproductive-aged women, with resultant increases in mother-to-child hepatitis C virus (HCV) transmissions in the U.S. Direct-acting antiviral (DAA) treatment is highly effective at reducing and eliminating the risk of HCV transmissions.
Yet, studies show lower odds of receiving DAA treatment for women compared to […] Announcing the 10th Pilot Grant Cohort Advancing the Treatment of Substance Use Disorders, HCV, and HIV CHERISH is excited to welcome a new pilot grant cohort for the 10th year.
Spearheaded by CHERISH Pilot Grant Program Director Brandon Aden, the program is designed to help researchers gain familiarity with health economic evaluations, apply related methodologies to their pilot research, and build out the next stage of their careers. This year, CHERISH […] Learn more about the pilot grant experience View Funded Pilots Request more information
According to the current listing, eligibility includes: Early-career researchers affiliated with Weill Cornell Medicine, University of Minnesota, Thomas Jefferson University, and Stanford University. Confirm the full requirements in the official notice before applying.
The current listing shows up to $20,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
CHERISH Pilot Grant Program is funded by CHERISH Research. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Minnesota. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.